Drug delivery for treatment of inner ear disease: current state of knowledge - Wikidata - awgldk - TriplyDB

Drug delivery for treatment of inner ear disease: current state of knowledge

Drug delivery for treatment of inner ear disease: current state of knowledge

http://www.wikidata.org/entity/Q30476020

about

Prevention and restoration of hearing loss associated with the use of cisplatin.Intracochlear drug delivery in combination with cochlear implants : Current aspects [Intracochlear drug delivery in combination with cochlear implants : Current aspects].Cisplatin-Associated Ototoxicity: A Review for the Health Professional Biohybrid cochlear implants in human neurosensory restoration.Protein transduction therapy into cochleae via the round window niche in guinea pigs.Rescuing the Cochlea: the challenges Intratympanic dexamethasone injections for refractory Meniere' s disease A single dose of dexamethasone encapsulated in polyethylene glycol-coated polylactic acid nanoparticles attenuates cisplatin-induced hearing loss following round window membrane administration Microsystems technologies for drug delivery to the inner ear.Lineage analysis of the late otocyst stage mouse inner ear by transuterine microinjection of a retroviral vector encoding alkaline phosphatase and an oligonucleotide library.Intracochlear drug delivery systems.Clinical practice guideline: sudden hearing loss.Drug delivery to the ear.A novel multipurpose modular mini-endoscope for otology.Identification of small molecule inhibitors of cisplatin-induced hair cell death: results of a 10,000 compound screen in the zebrafish lateral line.Rhesus Cochlear and Vestibular Functions Are Preserved After Inner Ear Injection of Saline Volume Sufficient for Gene Therapy Delivery.Magnetic targeted delivery of dexamethasone acetate across the round window membrane in guinea pigs.Magnetic nanoparticle-based approaches to locally target therapy and enhance tissue regeneration in vivo Are intra-tympanically administered steroids effective in patients with sudden deafness? Implications for current clinical practice.Developments in delivery of medications for inner ear disease.Advances in nano-based inner ear delivery systems for the treatment of sensorineural hearing loss.The effect of surface charge of glycerol monooleate-based nanoparticles on the round window membrane permeability and cochlear distribution.Efficacy of different routes of administration for Coenzyme Q10 formulation in noise-induced hearing loss: systemic versus transtympanic modality.Mathematical modeling for local trans-round window membrane drug transport in the inner ear.Evaluation of intratympanic formulations for inner ear delivery: methodology and sustained release formulation testing.Congenital hearing loss.Noninvasive technique for monitoring drug transport through the murine cochlea using micro-computed tomography.Nanomedicine for Inner Ear Diseases: A Review of Recent In Vivo Studies.BDNF as otoprotectant in toxin-induced hearing loss.Gentamicin Applied to the Oval Window Suppresses Vestibular Function in Guinea Pigs.Fluvastatin protects cochleae from damage by high-level noise.The effect of initial treatment on hearing prognosis in idiopathic sudden sensorineural hearing loss: a nationwide survey in Japan.Development of a drug delivery system for the inner ear using poly(amino acid)-based nanoparticles.Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone: A Randomized Controlled Study.Microfabricated infuse-withdraw micropump component for an integrated inner-ear drug-delivery platform.Single intratympanic gentamicin injection in Ménière's disease: VOR change and prognostic usefulness.In-vitro perforation of the round window membrane via direct 3-D printed microneedles Comparison of the distribution pattern of PEG-b-PCL polymersomes delivered into the rat inner ear via different methods

P2860

Q26825493-599D96D1-A27A-4D12-8BD5-3997A4F74347 Q30313632-4A81A3BA-E2A5-4C71-8F17-03C7ECD87E46 Q30313814-BE804272-3101-4E75-993F-3D6BDB06C50D Q30365226-18358108-9D5D-45C5-A11E-674E14F43E70 Q30372209-551D84B8-72DB-45FD-8877-08FBC615084A Q30375640-25A2D38A-D69A-4F4F-AF94-4C676AA86918 Q30406078-E87F481F-6EBF-4DCD-9AF9-3E4F80716FC9 Q30408145-11EC15A6-68EC-4C50-9BEE-F24A9A3EC55D Q30411180-9BB0DB9E-908F-4FC0-8B91-C84D4089616D Q30447624-F2818FC5-AA60-4E2F-BEB7-3B45C35537D8 Q30451065-8576488E-1A3B-4FBC-902B-2DA2DB6A10BA Q30464082-7C21E74B-6A93-4045-AE11-B2C0890C6048 Q34258137-6BFA6671-E5E7-4F2B-8F6F-1DD675B40A96 Q34549540-B51ABF4F-F199-4F88-9227-9E5CA4277936 Q35334569-482D9472-9ED0-4C39-B63B-FC1F488C7428 Q35562356-FDFAB565-0BD0-4C5D-89DE-F02BD0A54F40 Q36413770-1D5908BA-922A-4B69-98A7-8F3838CD11A3 Q36467180-1E0AE257-0297-4803-9E25-1B840DF9CCAB Q36528148-E839F5AE-D56F-4608-B72A-87795FC4461A Q37919754-AE36B519-F363-4419-A2BD-2B5A8BF26B9A Q38096427-8F3192B2-0623-4391-9035-085B2FEE1A43 Q38706405-DC13F22A-9B89-4026-B813-125667402FCD Q39110356-7D0265A0-38ED-419F-9A6A-6ECF84047867 Q39637189-989F9D6E-E7FC-4B76-A7B1-C0428CC1C2B0 Q39954359-39EBFA61-8DCB-44CE-848F-8730D477D7B5 Q41856899-F983FA9C-041B-4918-BFB0-3805E8A8C1BD Q44259602-4A0BBE9C-9C85-4344-A471-F463835C4D30 Q46053474-6CF4BB24-96A3-4BEA-BF04-E152E08564F3 Q46425471-9571F625-29F5-4B17-8C64-FBD6C01D8DAA Q48370751-A53215A8-0163-457B-8126-1909AA2A7D57 Q48373452-AE47C164-C65E-4ED0-8024-A74642BA93F7 Q50301030-2657348D-4BBF-45A3-91F2-4383976BB972 Q50310028-C6DD9F78-546C-41A5-B6EC-7E4A73F1AAE7 Q50355924-1082ABE7-C5FB-45C1-87EE-C8CAE1F2F74D Q50425895-DCBB09BE-312C-4E19-B090-DCCB264071B3 Q53312095-BED590DE-B1B0-4580-8CE6-537A5AD6B93B Q53622367-7F915317-7116-400E-8156-77BEE408CD97 Q57095879-A06BD6ED-CF93-4EF8-A729-89ADE1B22344 Q58081938-DE75C641-2A44-4454-A835-027E13E3A5A3

P2860

Drug delivery for treatment of inner ear disease: current state of knowledge

http://www.wikidata.org/entity/Q30476020

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Drug delivery for treatment of inner ear disease: current state of knowledge

@ast

Drug delivery for treatment of inner ear disease: current state of knowledge

@en

type

label

Drug delivery for treatment of inner ear disease: current state of knowledge

@ast

Drug delivery for treatment of inner ear disease: current state of knowledge

@en

prefLabel

Drug delivery for treatment of inner ear disease: current state of knowledge

@ast

Drug delivery for treatment of inner ear disease: current state of knowledge

@en

P1433

Q30476020-166B0A1B-0EA6-44C5-866D-465D8793FB06

P1476

Q30476020-CFDEBC87-7293-4D8C-BA2A-5994273D42CB

P2093

Q30476020-0D33F7F5-6330-4C9E-8BCB-6964A812E8EB

Q30476020-45B996A8-EB97-444D-9797-28214E2478E3

Q30476020-70ED48ED-4B7E-45AD-A187-1EC851DDC509

Q30476020-A0D85171-F1B7-459B-90CD-98B8A04BAE2E

Q30476020-B259FC76-7FD0-4A35-8830-95807327613F

Q30476020-C0D009F2-ED36-40E9-BFD0-D0EA8C32CBBC

P2860

Q30476020-007B5958-29EE-4848-9430-D43358381CD0

Q30476020-00E768E3-6A83-421D-B843-16EEA4095FFE

Q30476020-01E1D855-8798-4714-9ACF-8109FBC9DCF7

Q30476020-05F25315-CC35-4C4D-B9F9-55361ACFA40C

Q30476020-0679B039-E363-422F-AA2C-87195F2FDD34

Q30476020-06CB728C-248B-4D00-B8D6-43C12AD1A23C

Q30476020-08A28FF5-B52E-475F-922F-03F9D0A830ED

Q30476020-0D834F7C-B4FB-4D2F-AAEF-227017BC45A4

Q30476020-0D87661C-A7A6-4197-A259-CF0F2EFD75CF

Q30476020-0DA9A95E-F529-4811-BD54-2E73051AE302

P304

Q30476020-09AE3243-3291-43AF-B68F-4F7FCD06117F

P31

Q30476020-10B89A87-0866-4CB8-96EF-EA01E241AE83

P356

Q30476020-F20F1AA0-00C4-4186-8666-2B445BA30FB9

P433

Q30476020-C86B8A97-89D4-4116-89EB-4B0463E335C0

P478

Q30476020-FDB2F754-0F97-4FC4-98D2-702718086B02

P577

Q30476020-CCE13C4C-2306-4153-8472-9DA8FC4331B5

P698

Q30476020-E899791C-9342-432E-96E3-9E962C3B443E

P921

Q30476020-46B18786-E8DA-413D-8623-72CB76E11E47

P932

Q30476020-7AC1A333-81F8-4769-8B5F-482E4ECE5D2A

P356

AUD.0B013E3181C351F2

P1433

Ear and Hearing

P1476

Drug delivery for treatment of inner ear disease: current state of knowledge

@en

P2093

Andrew A McCall

http://www.w3.org/2001/XMLSchema#string

Erin E Leary Swan

http://www.w3.org/2001/XMLSchema#string

Jeffrey T Borenstein

http://www.w3.org/2001/XMLSchema#string

Michael J McKenna

http://www.w3.org/2001/XMLSchema#string

Sharon G Kujawa

http://www.w3.org/2001/XMLSchema#string

William F Sewell

http://www.w3.org/2001/XMLSchema#string

P2860

Steroids for idiopathic sudden sensorineural hearing loss

Progress towards in vivo use of siRNAs

The intratympanic treatment of Menière's disease with ototoxic antibiotics. A follow-up study of 55 cases (author's transl)

Acoustic plus electric speech processing: preliminary results of a multicenter clinical trial of the Iowa/Nucleus Hybrid implant.

Combined acoustic and electric hearing: preserving residual acoustic hearing.

Differential distribution of stem cells in the auditory and vestibular organs of the inner ear.

Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons.

Localized cell and drug delivery for auditory prostheses.

Development of a microfluidics-based intracochlear drug delivery device.

Local drug delivery with a self-contained, programmable, microfluidic system.

P304

156-165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/AUD.0B013E3181C351F2

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19952751

http://www.w3.org/2001/XMLSchema#string

P921

P932

2836414

http://www.w3.org/2001/XMLSchema#string